Children and adolescents , 5-18years old , with moderate-to-severe seasonal allergic rhinoconjunctivitis to grass pollen requiring daily administration of nasal corticosteroid ( NCS ) ( mometasone ) were recruited ( April 2013 ) in a paediatric allergy practice .